This list includes selected publications and web-resources, which have substantially informed this manual or that are recommended for further reading. Throughout the manual, a number of further references are provided where this was judged useful because it allows the reader to appraise the evidence supporting specific information, advice or guidance.

Printed publications

Access To Essential Medicines Initiative. (2008) Playing by the Rules: Using Intellectual Property Law and Policy to Improve Access to Essential Medicines. New York: Open Society Institute.

American Association for the Study Liver Diseases (AASLD) Practice Guidelines (2009) Diagnosis, Management, and Treatment of Hepatitis C: An Update

Burrows D (2003) Training Guide For HIV Prevention Outreach to Injecting Drug Users, Geneva: WHO Dept. Of HV/AIDS Prevention

Butt, G., Paterson, B.L. and McGuinness, L.K. (2007). Living with the stigma of hepatitis C. Western Journal of Nursing Research, 30 (2), 204–21.

Collins S and Swan T (2009) Guide to hepatitis C for people living with HIV. London: iBase.,, This guide is also available in Bulgarian, Czech, Portuguese and Russian

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2010), Annual Report 2010. Lisbon: EMCDDA.

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2010), Guidelines for testing HIV, viral hepatitis and other infections in injecting drug users, EMCDDA Manuals, Lisbon.

Franciscus A (2009) Hepatitis C: Support Group Manual. San Francisco: Hepatitis C Support Project. (

Guba, E (1987) Naturalistic Evaluation. In D.S. Cordray, H.S. Bloom & R.J. Light (Eds) Evaluation practice in review (New Directions for Programme Evaluation, No. 34, pp 23-43). San Francisco, Jossey-Bass

Guba, E & Lincoln, Y (1989) Fourth Generation Evaluation London, Sage Publications.

Harm Reduction Coalition - Hepatitis C Support Groups For Drug Users (undated)

Hepatitis NSW (2010) Hepatitis C factsheet - Test discussion (counselling), Hepatitis NSW, last reviewed May 2010; Accessed 29th March, 2011

Hoover J. (2009) Shining a Light on a Hidden Epidemic: Why and How Civil Society Advocates Can Support the Expansion of Hepatitis C Treatment in Eastern Europe and Central Asia. Access To Essential Medicines Initiative. New York: Open Society Institute.

Joseph S (undated) Hepatitis C: Pre and Post-Test Issues; Accessed 29th March, 2011

Lloyd C (2010) Sinning and Sinned Against: The Stigmatisation of Problem Drug Users. London: The UK Drug Policy Commission.

McCoy R et al. (2003) Hepatitis C an update – Pre-test counselling and diagnosis. Reprinted from Australian Family Physician Vol 32, No. 10, October 2003; Accessed 29th March, 2011

Merkinaite S and Knerr W (Eds.) (2007) Hepatitis C among injecting drug users in the new EU member states and neighboring countries: situation, guidelines and recommendations. Vilnius: Central and Eastern European Harm Reduction Network (CEEHRN).

Swan T, Chou L, Kaplan K, and Suwannawong P (2010) Training manual for treatment advocates: Hepatitis B, Hepatitis C, & Coinfection with HIV. New York: TAG, Bangkok: TAAG.

TAG (2008) Guide to hepatitis C for people living with HIV: testing, coinfection, treatment, and support. New York: Treatment Action Group.

Van de Laar T et al. (2009) Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology. 136, (5) :1609-17.

Van den Berg C, Smit C, Van Brussel G, Coutinho R & Prins M, (2007) Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Addiction.102 (9) : 1454–1462.

Vandelli C et al. (2004) Lack of Evidence of Sexual Transmission of Hepatitis C among Monogamous Couples: Results of a 10-Year Prospective Follow-Up Study. American Journal of Gastroenterology. 99,(6) : 855-859.

World Health Organisation (2010) Viral cancers. ;; Accessed 29th March, 2011

Websites/pages and other electronic publications

The Hepatitis C Trust

HCV Advocate

National Center for Complementary and Alternative Medicine, National Institutes of Health

index ¦ top